| P2093 | author name string | Kai-Lin Yang | |
| | Hui-Yong Huang | |
| | Wei-Qing Li | |
| | Shi-Ying Zhang | |
| | Zhi-Yong Long | |
| P2860 | cites work | An automated method for finding molecular complexes in large protein interaction networks | Q21284295 |
| | Epidemiologic and economic consequences of the global epidemics of obesity and diabetes | Q22251061 |
| | Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders | Q24558589 |
| | Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy | Q26775037 |
| | TCMSP: a database of systems pharmacology for drug discovery from herbal medicines | Q27703005 |
| | Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 |
| | Information flow analysis of interactome networks | Q28475566 |
| | The MIntAct project--IntAct as a common curation platform for 11 molecular interaction databases | Q28660703 |
| | Evidence for antiradical and antioxidant properties of four biologically active N,N-Diethylaminoethyl ethers of flavaone oximes: A comparison with natural polyphenolic flavonoid rutin action | Q29302214 |
| | Network medicine: a network-based approach to human disease | Q29547462 |
| | STRING v10: protein-protein interaction networks, integrated over the tree of life | Q29615545 |
| | Diabetic cardiomyopathy: pathophysiology and clinical features | Q30457504 |
| | Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte | Q32055216 |
| | Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction | Q33568098 |
| | Biochemical pathways of caspase activation during apoptosis | Q33804316 |
| | Activation of protein kinase C isoforms and its impact on diabetic complications | Q33881442 |
| | PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach | Q33957682 |
| | Diabetic cardiomyopathy, causes and effects | Q34038623 |
| | Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives | Q34289211 |
| | Melatonin ameliorates metabolic risk factors, modulates apoptotic proteins, and protects the rat heart against diabetes-induced apoptosis | Q46251063 |
| | Cardiomyocyte apoptosis induced by short-term diabetes requires mitochondrial GSH depletion | Q46417518 |
| | Uncovering the Pharmacological Mechanism of Astragalus Salvia Compound on Pregnancy-Induced Hypertension Syndrome by a Network Pharmacology Approach | Q47141505 |
| | Comparative efficacy of Chinese herbal injections for treating chronic heart failure: a network meta-analysis. | Q48131776 |
| | Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stress | Q48515611 |
| | Cardioprotection of Sheng Mai Yin a classic formula on adriamycin induced myocardial injury in Wistar rats | Q50097401 |
| | Molecular mechanisms of cardiac pathology in diabetes - Experimental insights. | Q50133076 |
| | Study on the protective effect of shengmai san (see text) on the myocardium in the type 2 diabetic cardiomyopathy model rat. | Q54343681 |
| | Exploring the Pharmacological Mechanism of Danzhi Xiaoyao Powder on ER-Positive Breast Cancer by a Network Pharmacology Approach. | Q54941668 |
| | Stemming the global tsunami of cardiovascular disease | Q57110191 |
| | Shengmai San Alleviates Diabetic Cardiomyopathy Through Improvement of Mitochondrial Lipid Metabolic Disorder | Q58079258 |
| | Trimetazidine and Other Metabolic Modifiers | Q61454288 |
| | Metformin improves cardiac function in isolated streptozotocin-diabetic rat hearts | Q72324128 |
| | Myocardial cell death in human diabetes | Q73281473 |
| | Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy | Q79257400 |
| | Ophiopogonin D prevents H2O2-induced injury in primary human umbilical vein endothelial cells | Q82552915 |
| | Identification of multiple constituents in the traditional Chinese medicine formula Sheng-Mai San and rat plasma after oral administration by HPLC-DAD-MS/MS | Q83057129 |
| | α-Lipoic acid increases tolerance of cardiomyoblasts to glucose/glucose oxidase-induced injury via ROS-dependent ERK1/2 activation | Q83515190 |
| | Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice | Q86248670 |
| | Shengmai injection reduces apoptosis and enhances angiogenesis after myocardial ischaemia and reperfusion injury in rats | Q88870529 |
| | Novel approaches in the treatment of diabetic cardiomyopathy | Q91006633 |
| | Ophiopogonin D Reduces Myocardial Ischemia-Reperfusion Injury via Upregulating CYP2J3/EETs in Rats | Q91510690 |
| | Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression | Q34789045 |
| | Oxidative stress and diabetic cardiomyopathy: a brief review | Q34817248 |
| | Enhanced cardiac Akt/protein kinase B signaling contributes to pathological cardiac hypertrophy in part by impairing mitochondrial function via transcriptional repression of mitochondrion-targeted nuclear genes. | Q35069561 |
| | Chinese herbal prescriptions for osteoarthritis in Taiwan: analysis of National Health Insurance dataset | Q35114033 |
| | A proteomic study of Shengmai injection's mechanism on preventing cardiac ischemia-reperfusion injury via energy metabolism modulation | Q35452821 |
| | Genetic loss of insulin receptors worsens cardiac efficiency in diabetes. | Q35892530 |
| | Naringenin attenuates pressure overload-induced cardiac hypertrophy | Q36334626 |
| | Sustained βAR Stimulation Mediates Cardiac Insulin Resistance in a PKA-Dependent Manner. | Q36415798 |
| | The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction | Q36519364 |
| | Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways | Q36783984 |
| | Insulin resistance: metabolic mechanisms and consequences in the heart. | Q36821424 |
| | Diabetic cardiomyopathy revisited | Q36860318 |
| | Shengmai San Ameliorates Myocardial Dysfunction and Fibrosis in Diabetic db/db Mice. | Q36870324 |
| | Metabolic dysfunction in diabetic cardiomyopathy | Q36930481 |
| | Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. | Q37335886 |
| | β-Adrenergic Receptor and Insulin Resistance in the Heart | Q37551918 |
| | Molecular mechanisms of diabetic cardiomyopathy. | Q37672583 |
| | Modulation of myocardial metabolism: an emerging therapeutic principle. | Q37763834 |
| | Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways | Q38181816 |
| | Endoplasmic reticulum stress and protein quality control in diabetic cardiomyopathy | Q38213336 |
| | Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets | Q38545752 |
| | Cellular and molecular mechanisms of HGF/Met in the cardiovascular system. | Q38631649 |
| | Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure | Q38652938 |
| | Exogenous Hydrogen Sulfide Attenuates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation by Suppressing TLR4/NF-κB Pathway in H9c2 Cells. | Q38725221 |
| | The role of AMPK in cardiomyocyte health and survival | Q38895778 |
| | Insulin and β Adrenergic Receptor Signaling: Crosstalk in Heart | Q39159635 |
| | Trimetazidine in conditions other than coronary disease, old drug, new tricks? | Q39159649 |
| | An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. | Q39232014 |
| | Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents | Q40238333 |
| | Atorvastatin alleviates experimental diabetic cardiomyopathy by suppressing apoptosis and oxidative stress | Q40871248 |
| | Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure. | Q41297700 |
| | Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice | Q42517491 |
| | The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study | Q43636295 |
| | Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats | Q45135925 |
| | Zinc deficiency exacerbates while zinc supplement attenuates cardiac hypertrophy in high-fat diet-induced obese mice through modulating p38 MAPK-dependent signaling | Q45295876 |
| | Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes. | Q45812025 |
| | Inhibiting Insulin-Mediated β2-Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction. | Q46138106 |
| | PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway | Q46158612 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P921 | main subject | diabetic cardiomyopathy | Q5270132 |
| P304 | page(s) | e919029 | |
| P577 | publication date | 2020-02-05 | |
| P1433 | published in | Medical Science Monitor | Q15756323 |
| P1476 | title | Use of a Systematic Pharmacological Methodology to Explore the Mechanism of Shengmai Powder in Treating Diabetic Cardiomyopathy | |
| P478 | volume | 26 | |